|
Bohren, Kurt M; Brownlee, June M; Milne, Amy C et al. (2005) The structure of Apo R268A human aldose reductase: hinges and latches that control the kinetic mechanism. Biochim Biophys Acta 1748:201-12
|
|
Barski, Oleg A; Siller-Lopez, Fernando; Bohren, Kurt M et al. (2004) Human aldehyde reductase promoter allows simultaneous expression of two genes in opposite directions. Biotechniques 36:382-4, 386, 388
|
|
Barski, Oleg A; Papusha, Victor Z; Kunkel, Gary R et al. (2004) Regulation of aldehyde reductase expression by STAF and CHOP. Genomics 83:119-29
|
|
Gabbay, Kenneth H (2004) Aldose reductase inhibition in the treatment of diabetic neuropathy: where are we in 2004? Curr Diab Rep 4:405-8
|
|
Sheikh-Hamad, D; Nadkarni, V; Choi, Y J et al. (2001) Cyclosporine A inhibits the adaptive responses to hypertonicity: a potential mechanism of nephrotoxicity. J Am Soc Nephrol 12:2732-41
|
|
Bohren, K M; Grimshaw, C E (2000) The sorbinil trap: a predicted dead-end complex confirms the mechanism of aldose reductase inhibition. Biochemistry 39:9967-74
|
|
Barski, O A; Gabbay, K H; Bohren, K M (1999) Characterization of the human aldehyde reductase gene and promoter. Genomics 60:188-98
|
|
Nadkarni, V; Gabbay, K H; Bohren, K M et al. (1999) Osmotic response element enhancer activity. Regulation through p38 kinase and mitogen-activated extracellular signal-regulated kinase kinase. J Biol Chem 274:20185-90
|
|
Ko, B C; Ruepp, B; Bohren, K M et al. (1997) Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene. J Biol Chem 272:16431-7
|
|
Harrison, D H; Bohren, K M; Petsko, G A et al. (1997) The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant. Biochemistry 36:16134-40
|
Showing the most recent 10 out of 15 publications
